首页> 外国专利> Method of drug loading in cell-derived membrane vesicles by engineering parent cells with membrane fusogenic liposomes and drug delivery method using thereof

Method of drug loading in cell-derived membrane vesicles by engineering parent cells with membrane fusogenic liposomes and drug delivery method using thereof

机译:通过用膜融合脂质体改造亲代细胞而在细胞衍生的膜囊泡中载药的方法及其使用的药物递送方法

摘要

The present invention relates to a membrane vesicle in which a prepared drug is included using a membrane fusogenic liposome (MFL), a membrane vesicle preparation method, and a drug delivery method using the membrane vesicle. Specifically, the membrane vesicle of the present invention allows hydrophilic and hydrophobic drugs to be simultaneously included therein, is isolated from a cell to facilitate more efficient and selective drug delivery to neighboring cells, and is safe as a nanomaterial derived from a living body, and a step for directly entrapping the drug in the membrane vesicle is unnecessary. Therefore, the membrane vesicle can be effectively used for preventing and treating a variety of cancers and degenerative diseases in which the membrane vesicle is known to play an important role.
机译:膜囊泡,膜囊泡的制备方法以及膜囊泡的给药方法技术领域本发明涉及一种膜囊泡,其中使用膜融合脂质体(MFL)制备的药物,膜囊泡的制备方法以及使用该膜囊泡的给药方法。具体地,本发明的膜囊泡允许亲水性和疏水性药物同时被包含在其中,并从细胞分离以促进更有效和选择性地将药物递送至相邻细胞,并且作为衍生自活体的纳米材料是安全的,并且不需要将药物直接包埋在膜囊泡中的步骤。因此,膜囊泡可有效地用于预防和治疗其中已知膜囊泡起重要作用的多种癌症和变性疾病。

著录项

  • 公开/公告号KR20150046709A

    专利类型

  • 公开/公告日2015-04-30

    原文格式PDF

  • 申请/专利权人 한국과학기술원;

    申请/专利号KR20140032446

  • 发明设计人 박지호;이준성;김지영;

    申请日2014-03-20

  • 分类号A61K9/127;A61K47/30;A61K47/48;

  • 国家 KR

  • 入库时间 2022-08-21 15:00:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号